Development and Validation of a Novel Functional Eye-Tracking Software Application for Neurological Disorders

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

SUSPENDED

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-04-15

Study Completion Date

2024-05-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to develop and validate a sensitive and non-invasive eye-tracking software application.

This study will obtain participant responses to brief cognitive tests designed to evaluate several key functions known to be affected by neurological disorders and non-invasive eye movement measurements in response to visually presented stimuli during specifically designed eye-tracking tests. The study data will be used to develop machine learning algorithms and validate a software application intended to track the progressive component of neurological disorders and associated cognitive changes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Investigating Eye-Movement Biomarkers of Disease Severity and Cognition in Multiple Sclerosis

NCT05661266

Multiple Sclerosis

UNKNOWN

An Examination of Cognitive and Sensorimotor Processes in Patients With Epilepsy

NCT00859794

Epilepsy

ENROLLING_BY_INVITATION NA

Study of Eye Movements as Markers of the Physiological, Cerebral and Cognitive State of Healthy Subjects

NCT04325971

Healthy

COMPLETED NA

Transfer of Neural Energy Between Humans

NCT00029978

Healthy

COMPLETED

Brain Stimulation and Vision Testing

NCT01617408

fMRI Dorsal Pathway Ventral Pathway

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neurological Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy Control

Participant with no evidence or history of significant neurodegenerative disorder affecting brain function.

Eye-tracking

Intervention Type DEVICE

Eye-tracking technology and algorithms used to successfully capture and track eye movements using an electronic tablet and the embedded camera of the device.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Eye-tracking

Eye-tracking technology and algorithms used to successfully capture and track eye movements using an electronic tablet and the embedded camera of the device.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 18 years old and above
* A score of ≥ 26 on the Montreal Cognitive Assessment (MoCA)
* Able to provide informed consent
* Visual acuity of 20/100 in at least one eye (corrective glasses, contact lenses, surgery etc are permitted).

Exclusion Criteria

* Evidence or medical history of psychiatric issues, which are known to also affect movements and oculomotor control.
* Evidence or history of significant neurological disorder (e.g. MS, PD, ALS, Dementia)
* Use of prescription drugs known to influence ocular motor visual function, such as benzodiazepines, antipsychotics, and anticonvulsants.
* Diagnosed with an active substance use disorder.
* History of stroke.
* Recent traumatic brain injury (within the last 6 months).

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No